Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

about

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.

P2860

Q30390832-912DD09F-7EBC-4A80-82DC-C3A3699874CC

P2860

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

Item

http://www.wikidata.org/entity/Q35866636

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@ast

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@en

type

Item

label

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@ast

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@en

prefLabel

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@ast

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@en

P1476

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

@en

P2093

C Buddy Creech

http://www.w3.org/2001/XMLSchema#string

David B Corry

http://www.w3.org/2001/XMLSchema#string

Emmanuel B Walter

http://www.w3.org/2001/XMLSchema#string

Heather Hill

http://www.w3.org/2001/XMLSchema#string

Innocent N Mbawuike

http://www.w3.org/2001/XMLSchema#string

Johannes B Goll

http://www.w3.org/2001/XMLSchema#string

Rebecca C Brady

http://www.w3.org/2001/XMLSchema#string

Sharon E Frey

http://www.w3.org/2001/XMLSchema#string

Shital M Patel

http://www.w3.org/2001/XMLSchema#string

Wilbur H Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A highly conserved neutralizing epitope on group 2 influenza A viruses

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

Cellular immune correlates of protection against symptomatic pandemic influenza.

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

P304

547-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2015.11.055

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26657997

http://www.w3.org/2001/XMLSchema#string

P932

4713282

http://www.w3.org/2001/XMLSchema#string

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

about

P2860

P2860

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932